Lokomat Treadmill Training Effects on MS Gait

Sponsor
Mount Sinai Rehabilitation Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00835835
Collaborator
(none)
8
1
2
64
0.1

Study Details

Study Description

Brief Summary

This study is being done to test the possible benefits of gait-specific training using body-weight supported, Lokomat assisted, treadmill training in people with Multiple Sclerosis.

Condition or Disease Intervention/Treatment Phase
  • Other: Body-weight supported treadmill training +/- Lokomat assistance
  • Other: Usual Care - no active intervention
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
8 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Lokomat Treadmill Training Effects on MS Gait
Study Start Date :
Feb 1, 2008
Actual Primary Completion Date :
Oct 1, 2011
Actual Study Completion Date :
Jun 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Control group

The placebo group did not receive treatment during the matched period yet did undergo all assessments. The MS Placebo group received equal treatment following the study intervention period.

Other: Usual Care - no active intervention
No treatment used for comparison
Other Names:
  • control group
  • Experimental: Combination Treadmill training group

    Subjects randomized to Combination therapy received 20 minutes of Lokomat assisted treadmill training followed by up to 20 minutes of BWS treadmill training (without robotic assistance) twice a week.

    Other: Body-weight supported treadmill training +/- Lokomat assistance
    walking
    Other Names:
  • Lokomat
  • Outcome Measures

    Primary Outcome Measures

    1. Gait Parameters [Baseline, throughout study enrollment and 2 months follow-up]

    Other Outcome Measures

    1. 6 minute walk [Baseline, throughout study enrollment and 2 months follow-up]

      The 6 minute walk test is measured on a treadmill. The subject is asked to indicate the most comfortable treadmill speed to the therapist. The subject is instructed to walk as far as possible in 6 minutes and the total distance covered in 6 minutes is recorded. A harness, without body-weight support, is attached for safety.

    2. MSQLI (Multiple Sclerosis Quality of Life Index) [Baseline, throughout study enrollment and 2 months follow-up]

      The MSQLI is a battery consisting of 10 individual scales providing a quality of life measure that is both generic and MS-specific (Fischer et al, 1999). The MS quality of life index is a validated instrument used in accessing multiple aspects of quality of life for persons with MS. It is a modification of the short-form health survey (SF-36) and requires about 30-45 minutes to complete.

    3. Timed 25-foot walk [Baseline, throughout study enrollment and 2 months follow-up]

      Will be collected over-ground and on a straight 25-foot GaitRite electronic mat. The subject will be timed over the 25-foot distance both at their self-designated usual pace and at the fastest safe pace possible. Data will be collected using a laptop computer. The GaitRite system has software to calculate several measures including velocity, stride length, base width and number of steps.

    4. Frequency of Falls [Baseline, throughout study enrollment and 2 months follow-up]

      Falls will be recorded by the subjects onto a "Falls Calender" provided to the subjects. Subjects will be given the following definition of a fall: "an event which results in a person coming to rest inadvertently on the ground or other lower level, and other than as a consequence of the following: sustaining a violent blow; loss of consciousness; sudden onset of paralysis, as in a stroke and an epileptic seizure" (Vellas 1992).

    5. FRT (Functional Reach Test) [Baseline, throughout study enrollment and 2 months follow-up]

      The Functional Reach test is a measure of balance and is the difference from arm's length and maximal forward reach. The support case is fixed. The test utilizes a 48-inch measuring device or "yardstick" for measuring functional reach. Data is measured in inches (Duncan P. W. et al 1990).

    6. CDP (Computerized Dynamic Posturography) [Baseline, throughout study enrollment and 2 months follow-up]

      NeuroCom Smart Balance Master system. The use of CDP has allowed clinicians to objectively measure the postural components of balance (Liston 1996). CDP assesses sway by measuring shifts in the center of gravity (COG) as a person moves within the available limits of stability (LOS). Two types of tests will be used with CDP; they are the Sensory Organization Test (SOT) and the LOS test. SOT: measures sway and is designed to quantify an individual's ability to maintain balance in a variety of complex sensory conditions. LOS: measures volitional control of the COG. Test measures include maximum end-point excursion for anterior, posterior, right, and left movements.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    25 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Main Inclusion Criteria:
    • Clinical diagnosis of MS

    • EDSS level between 3.5-6.0

    • Problems with ambulation

    • able to ambulate 25 feet without an assistive device

    Main Exclusion Criteria:
    • Lower extremity injuries that limit range of motion or function

    • Unable to demonstrate an understanding of the process of the study and or fully understand instructions in order to safely participate in the study and use study equipment

    • Body weight over 150 kg

    • complete inclusion/exclusion criteria listed in consent form

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mandell Center for Multiple Sclerosis at Mt. Sinai Rehabilitation Hospital Hartford Connecticut United States 06112

    Sponsors and Collaborators

    • Mount Sinai Rehabilitation Hospital

    Investigators

    • Principal Investigator: Albert Lo, MD, PhD, Mandell Center for Multiple Sclerosis at Mount Sinai Rehabilitation Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Jennifer Ruiz, DPT, Research Manager, Mount Sinai Rehabilitation Hospital
    ClinicalTrials.gov Identifier:
    NCT00835835
    Other Study ID Numbers:
    • AL0001
    First Posted:
    Feb 4, 2009
    Last Update Posted:
    Nov 11, 2015
    Last Verified:
    Nov 1, 2015
    Keywords provided by Jennifer Ruiz, DPT, Research Manager, Mount Sinai Rehabilitation Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 11, 2015